UCB S.A. (ADR)
General ticker "UCBJY" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $40.9B (TTM average)
UCB S.A. (ADR) follows the US Stock Market performance with the rate: 56.0%.
Estimated limits based on current volatility of 1.6%: low 144.51$, high 149.08$
Factors to consider:
- Company pays dividends (annually): last record date 2025-04-28, amount 0.79$ (Y0.54%)
Short-term UCBJY quotes
Long-term UCBJY plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €5,252.00MM | €6,152.00MM | €7,435.48MM |
| Operating Expenses | €4,648.00MM | €4,828.00MM | €6,315.50MM |
| Operating Income | €604.00MM | €1,324.00MM | €1,119.98MM |
| Non-Operating Income | €-163.00MM | €-161.00MM | €630.11MM |
| Interest Expense | €144.00MM | €171.99MM | €122.95MM |
| R&D Expense | €1,630.00MM | €1,781.00MM | €1,750.09MM |
| Income(Loss) | €441.00MM | €1,163.00MM | €1,750.09MM |
| Taxes | €98.00MM | €98.00MM | €253.58MM |
| Profit(Loss)* | €343.00MM | €1,065.00MM | €1,496.51MM |
| Stockholders Equity | €8,975.00MM | €10,029.00MM | €10,862.37MM |
| Inventory | €1,031.00MM | €1,309.00MM | €1,495.36MM |
| Assets | €15,539.00MM | €17,347.00MM | €18,150.27MM |
| Operating Cash Flow | €761.00MM | €1,242.00MM | €2,077.63MM |
| Capital expenditure | €316.00MM | €322.00MM | €269.91MM |
| Investing Cash Flow | €-440.00MM | €282.00MM | €-373.65MM |
| Financing Cash Flow | €-308.00MM | €-818.00MM | €-1,043.14MM |
| Earnings Per Share** | €0.88 | €2.80 | €3.94 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.